Not just data
Alongside clinical and biological inputs, it emphasizes treatment continuity, symptom visibility, and day-to-day care flow.
Onco Atlas
From fragmented data to structured context.
Turning the whisper of cells into decisions.
- Built around oncology workflow realities
- Designed for continuity of care
- Structured for pilot evaluation
- Patient-journey focused
Data Policy
Data is not stored. It is analyzed and automatically deleted at the end of the session.
Important Notice
Demo outputs must not be used for clinical diagnosis or treatment decisions.
FHIR v4.0 Compliant (Self-declared)
SaMD scope & regulatory readiness roadmap
Integration
- Ready for HIS interoperability (HL7 FHIR v4.0)
- Enterprise-grade data model and scalable backend
Certification
- SaMD (Software as a Medical Device) scope
- MDR / CE and FDA pathways: preparation & documentation
Global Alignment
- Architecture built for interoperability and clinical workflow support integration
Regulatory and quality readiness are managed as an active, structured component of Zynova's long-term product strategy.
⚠️This report was developed by Zynova Sağlık Teknolojileri Ltd. Şti. and is intended solely for clinical decision support purposes. It does not constitute medical diagnosis or treatment recommendation. All clinical decisions and treatment implementations remain the sole responsibility of the licensed physician evaluating the patient. This content does not replace the physician-patient relationship under any circumstances.
Why Zynova?
Many oncology platforms focus on analyzing data. Zynova focuses on making the patient journey more visible, trackable, and manageable.
Not just for institutions
It supports institutional workflows while also addressing the less visible gaps between patients and care teams.
Not just analysis
It turns fragmented treatment steps and symptom signals into structured documentation and evidence navigation for clinical review support.
Zynova is built not only to understand cancer data, but to make the cancer journey easier to navigate.
What Zynova OncoAtlas Does
An AI-assisted oncology workflow intelligence and evidence navigation platform — structured around how oncology teams prepare cases, navigate evidence, and maintain continuity of care.
- Structures fragmented patient data into a structured oncology timeline
- Supports evidence navigation across guidelines, trials, and genomic context
- Streamlines tumor board preparation and care handoffs between teams
- Designed for clinical workflow support — not treatment automation or automated diagnosis
A new cancer diagnosis appears every 2 minutes.
A physician has 15 minutes in hand.
The latest research was published 6 hours ago.
No one can read everything.
Zynova was built to close this gap.
4,495+
January 2026 publication scale; prioritized for case context
260
Source updates are processed to keep matching context current
Continuous
Open data is structured into traceable, rationale-backed clinical output
73%
Cross-country reimbursement variance
Key Capabilities
Structured Oncology Timeline
Consolidates imaging, pathology, labs, and notes into a structured oncology timeline that supports clinical reasoning across the care pathway.
🧬
3D Anatomical Context
Visualizes tumor location and spread for tumor board preparation and multidisciplinary discussion — designed for clinical workflow support.
Evidence Navigation for Trials
Filters trial sources by case context with traceable rationale — evidence navigation for physician-led review, not automated trial assignment.
Guideline & Protocol Context
Surfaces NCCN, ESMO, and ASCO reference context alongside formulary signals to support protocol discussion — not guaranteed treatment protocols.
Genomic Context Layer
Maps biomarker and genomic findings to anatomy-aware summaries that support interpretation; the physician remains the final decision-maker.
Tumor Board Preparation
Prepares structured case materials for tumor boards and remote multidisciplinary reviews without replacing physician judgment.
Clarity for institutional evaluation
Product choices reflect clinical process realities, continuity of care, and patient-journey needs — not hype.
Clinical relevance
Reflects familiar pressures in oncology practice: document load, protocol discussion, and multidisciplinary coordination.
Patient journey
A single-timeline mindset from diagnosis through follow-up — visibility and continuity as care transitions between teams.
Institutional readiness
Structured with scoped pilots and feedback loops in mind — focused on operational fit, not headline claims.
This section carries no diagnosis, approval, or reimbursement commitment — it summarizes how the product is positioned.
Human-in-the-Loop Clinical Support
Zynova supports clinical reasoning and evidence navigation. It does not diagnose, prescribe, or replace licensed physicians. Every output is prepared for physician review and tumor board discussion.
Supports clinical reasoning; does not decide or recommend treatment
Structured outputs for physician review — not instant medical decisions
Physician remains the final decision-maker at every step
For Oncology Teams, Hospitals & Tumor Boards
🏥
Hospitals & cancer centers
Accelerate tumor board preparation, multidisciplinary meetings, and case intake with structured workflow intelligence — the physician remains the final decision-maker.
👥
Tumor boards & MDT teams
Case packets, evidence summaries, and continuity notes for board-ready discussion — supports clinical reasoning without issuing treatment directives.
🩺
Oncology practices & networks
Unify documents and timelines on one surface for evidence navigation and follow-up continuity across sites and handoffs.
Enterprise Readiness
Built for institutional evaluation: pilot pathways, role-aware access conversations, and workflow alignment with hospital and cancer-center operating models.
- Structured pilot evaluation and feedback cycles with defined scope
- Session-based processing boundaries aligned to clinical workflow support
- Deployment discussions scaled to team structure, tumor board cadence, and IT context
About Zynova
Zynova Global - OncoAtlas is a health technology company shaped by real oncology needs. Our focus is to make the patient journey more visible, trackable, and manageable.
Founder Perspective
Founded by Gokhan Dincaslan, with over 23 years across the oncology ecosystem, Zynova combines pharma and operational field experience with an innovation-focused product vision.
Explore content and workflow depth
Review concise, structured surfaces that explain not only what Zynova offers, but how it fits oncology workflow in practice.
Use Cases
Product application pages for case intake, trial matching, and report output workflows.
Insights
Short, problem-oriented pieces on oncology operations and clinical review preparation.
Knowledge Base
Foundational terms such as ECOG, biomarker context, and trial eligibility.
Clinical AI
Perspective on supporting workflow with AI without replacing physician judgment.
Explore the workflow before you commit.
No login required for first exploration. Designed for clinical workflow support — demo outputs are not for diagnosis.
After a short product tour, the demo lets teams evaluate workflow and patient-journey scenarios in a structured, low-risk way.
Zynova’s value is workflow intelligence and evidence navigation — structuring fragmented oncology data around tumor type, biomarker, stage, and clinical context so teams can prepare tumor boards and continuity handoffs more clearly.
The goal is not more records on screen, but clearer workflow support for physician-led review — the physician remains the final decision-maker.
400,000+
Broad trial coverage; case-aware prioritization over raw listing
Source: ClinicalTrials.gov + WHO ICTRP
1,000+
Genomic layer connected to report-ready interpretation flow
47
Cancer-type coverage presented in a structured clinician-facing format
Based on WHO ICD-O-3 major groups
23
Countries
~1 min
Sample turnaround for physician-readable report preview
Coverage
A broad data layer monitors information across relevant clinical sources and brings it into a single working surface.
Relevance
Data is prioritized according to case context, biomarker signals, stage, and clinical fit.
Usability
The result is a shortlist, rationale, and report-ready layer that physicians can review more efficiently.
Evidence & Validation Roadmap
Zynova OncoAtlas is in active R&D and beta evaluation. Rather than claiming clinical performance, it aims to transparently track pilot metrics such as data extraction, missing critical data detection, trial-shortlist relevance, and physician review time.
Report extraction
Missing critical data
Trial shortlisting
Physician review time
Beta Metrics
Beta Phase
Active development
47+
Cancer-type coverage structured for clinical context
400k+
Trial coverage filtered by case relevance, not raw listing
1000+
Genomic layer linked to interpretable report flow
Zynova OncoAtlas is in active R&D phase. Figures are periodically updated.
Evaluate Zynova for your oncology workflow
Request a clinical workflow walkthrough, explore platform surfaces, or discuss institutional pilot scope with our team.
Access Options
Beta access is currently available at no cost. Long-term access is expected to follow a structured institutional model based on scope, team configuration, and workflow requirements. Early pilot collaborations may include tailored access arrangements.
Demo Access
Free
- •Immediate, low-friction product exploration
- •Structured walkthrough with fictional patient journeys
- •No account required for first experience
Limited Capacity
Early Access
No-cost during beta phase
- •Feedback-driven usage with selected early users
- •Controlled access to core workflow intelligence capabilities
- •Tailored pilot scope discussions — Apply for Pilot Evaluation
By application
Institutional Access
Structured model
- •Designed to scale by team size, workflow depth, and deployment scope
- •Roles, workflow boundaries, and rollout context are jointly structured
- •Long-term access planning aligns with hospital and cancer-center operating needs
For corporate communication and partnership inquiries, please visit our Contact page.
Zynova OncoAtlas supports oncology workflow, evidence navigation, and clinical documentation. It does not diagnose, prescribe treatment, or replace licensed physicians.